Skip to main content
. Author manuscript; available in PMC: 2014 Oct 16.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Nov 22;85(5):1206–1211. doi: 10.1016/j.ijrobp.2012.10.008

Figure 1. Progression-Free Survival.

Figure 1

119 patients were identified to have been treated per protocol or with acceptable deviation. The progression free survival at 6 months was 40 %.

HHS Vulnerability Disclosure